Photos of Neeraj Agarwal and David Braun
Aug 4, 2024, 17:24
Neeraj Agarwal: Liquid epigenomic profiling to diagnose RCC patients with residual disease surgery
Neeraj Agarwal shared on X:
“Another stellar talk by David Braun in World GU Conference 2024
- How to diagnose Renal Cell Carcinoma (RCC) patients with residual disease after surgery?
- liquid epigenomic profiling, CTCs (shoutout to the great Josh Lang, Kim-1 and more”
Source: Neeraj Agarwal/X
Neeraj Agarwal is a Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), University of Utah. He also directs the Genitourinary Oncology (GU) Program, and the Center of Investigational Therapeutics (CIT) at the HCI.
Dr. Agarwal is an Advisor to the Oncology Drug Advisory Committee and the United States Food and Drug Administration, leads early therapeutics in the SWOG genitourinary cancers committee, and is the Chief Editor of ASCO Daily News.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 1, 2024, 19:12
Nov 1, 2024, 17:46
Nov 1, 2024, 17:41
Nov 1, 2024, 17:27